Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-001515
Filing Date
2025-01-07
Accepted
2025-01-07 06:04:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2432042-3_424b5.htm 424B5 444475
2 GRAPHIC lg_aeonbiopharma-4c.jpg GRAPHIC 14389
  Complete submission text file 0001104659-25-001515.txt   465561
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-281562 | Film No.: 25513386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)